Investing Goldman Sachs fancies Ferrari, Hermes, Novo Nordisk for European investorsGoldman analysts have advised European investors to favour growth stocks
Markets Novo’s wonderdrug Ozempic shakes up marketsDiabetes drug showed surprisingly early effectiveness in a kidney-failure study, rocking shares of dialysis providers
Pharma Novo Nordisk appoints new general manager for Ireland operationNina Hovland heads up Irish arm of Danish firm behind weight-loss-inducing drugs Wegovy and Ozempic
Pharma Equity fund forecasts weight-loss drug market frenzy far from finish line Capital Group fund says it sees long-term opportunity in the development of drugs like Novo’s Ozempic
